Crystal structure of human soluble adenylate cyclase
OwnerSusanne Maria Saalau-Bethell, Anne Cleasby +3inventors
InventorsSusanne Maria Saalau-Bethell, Anne Cleasby, Joseph Coyle, Mladen Vinkovic, Tracey Ann Sambrook
Life of this patent
Estimating the term…
Abstract
The invention provides the crystal structure of the solAC catalytic domain. The structure is set out in Tables 1 to 5. The structure may be used in to model the interaction of ligands such as pharmaceutical compounds with this protein, and to determine the structure of related adenylate cyclase molecules.
Claims41
A computer-based method for the analysis of the interaction of a ligand with a solAC structure, which comprises:
- providing a solAC structure which is of Table 1, Table 2, Table 3, Table 4 or Table 5, optionally varied by a root mean square deviation of not more than 1.5 Å, or selected coordinates thereof;
- providing a ligand to be fitted to said solAC structure or selected coordinates thereof;
- and
- fitting the ligand to said solAC structure.
A method of assessing the ability of a ligand to interact with solAC protein which comprises:
- obtaining or synthesising said ligand;
- forming a crystallized complex of a solAC protein and said ligand, said complex diffracting X-rays for the determination of atomic coordinates of said complex to a resolution of better than 3.5 Å;
- and
- analysing said complex by X-ray crystallography by employing the data of Table 1, Table 2, Table 3, Table 4 or Table 5, optionally varied by a root mean square deviation of not more than 1.5 Å, or selected coordinates thereof, to determine the ability of said ligand to interact with the solAC protein.
A method for determining the structure of a protein, which method comprises;
- providing the co-ordinates of Table 1, Table 2, Table 3, Table 4 or Table 5, optionally varied by a root mean square deviation of not more than 1.5 Å, or selected coordinates thereof, and
- either (a) positioning said co-ordinates in the crystal unit cell of said protein so as to provide a structure for said protein, or (b) assigning NMR spectra peaks of said protein by manipulating said co-ordinates.
A method of predicting three dimensional structures of solAC protein homologues or analogues of unknown structure, the method comprises the steps of:
- aligning a representation of an amino acid sequence of a target solAC protein of unknown three-dimensional structure with the amino acid sequence of the solAC of Table 1, Table 2, Table 3, Table 4 or Table 5, optionally varied by a root mean square deviation of not more than 1.5 Å, or selected coordinates thereof, to match homologous regions of the amino acid sequences;
- modelling the structure of the matched homologous regions of said target solAC of unknown structure on the corresponding regions of the solAC structure as defined by Table 1, Table 2, Table 3, Table 4 or Table 5, optionally varied by a root mean square deviation of not more than 1.5 Å, or selected coordinates thereof;
- and
- determining a conformation for said target solAC of unknown structure which substantially preserves the structure of said matched homologous regions.
A method of providing data for generating structures and/or performing optimisation of ligands which interact with solAC, solAC homologues or analogues, complexes of solAC with ligands, or complexes of solAC homologues or analogues with ligands, the method comprising:
- (i) establishing communication with a remote device containing
- (a) computer-readable data comprising atomic coordinate data of Table 1, Table 2, Table 3, Table 4 or Table 5, optionally varied by an rmsd of less than 1.5 Å, or selected coordinates thereof, said data defining the three-dimensional structure of solAC catalytic domain, or selected coordinates thereof;
- (b) atomic coordinate data of a target adenylate cyclase homologue or analogue generated by homology modelling of the target based on the data (a);
- (c) atomic coordinate data of a protein generated by interpreting X-ray crystallographic data or NMR data by reference to the data of Table 1, Table 2, Table 3, Table 4 or Table 5 and
- (d) structure factor data derivable from the atomic coordinate data of (a) or (c);
- and
- (ii) receiving said computer-readable data from said remote device.
A computer system, intended to generate structures and/or perform optimisation of ligands which interact with solAC, solAC homologues or analogues, complexes of solAC with ligands, or complexes of solAC homologues or analogues with ligands, the system containing computer-readable data comprising one or more of:
- (a) solAC co-ordinate data of Table 1, Table 2, Table 3, Table 4 or Table 5 said data defining the three-dimensional structure of solAC catalytic domain, or selected coordinates thereof;
- (b) atomic coordinate data of a target adenylate cyclase protein generated by homology modelling of the target based on the coordinate data of Table 1, Table 2, Table 3, Table 4 or Table 5;
- (c) atomic coordinate data of a target adenylate cyclase protein generated by interpreting X-ray crystallographic data or NMR data by reference to the co-ordinate data of Table 1, Table 2, Table 3, Table 4 or Table 5;
- (d) structure factor data derivable from the atomic coordinate data of (b) or (c).
- and
- (e) atomic coordinate data of Table 1, Table 2, Table 3, Table 4 or Table 5, optionally varied by an rmsd of less than 1.5 Å, or selected coordinates thereof.
The use of a computer for producing a three-dimensional representation of a solAC structure or a solAC-ligand complex wherein the solAC structure is of Table 1, Table 2, Table 3, Table 4 or Table 5, optionally varied by a root mean square deviation of not more than 1.5 Å, or selected coordinates thereof, wherein said computer comprises:
- (i) a machine-readable data storage medium comprising a data storage material encoded with machine-readable data, wherein said data comprise the structure of Table 1, Table 2, Table 3, Table 4 or Table 5, optionally varied by a root mean square deviation of not more than 1.5 Å, or selected coordinates thereof;
- (ii) instructions for processing said machine-readable data into said three-dimensional representation.
A crystal of solAC catalytic domain.
A co-crystal of solAC catalytic domain and a ligand.
A co-crystal of solAC catalytic domain and a ligand having a space group P63.
A crystal of solAC protein having a resolution of 3.5 Å or better.
A crystal of solAc protein having the structure defined by the co-ordinates of Table 1, Table 2, Table 3, Table 4 or Table 5, optionally varied by an rmsd of less than 1.5 Å.
Dependencies are inferred from the claim text.